{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-005384","form_type":"8-K","ticker":"IDYA","cik":"0001676725","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2022-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.754528+00:00","generated_at":"2026-06-26T09:08:10.286689+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"IDEAYA appoints Catherine Mackey, Ph.D. to Board of Directors","bullets":["Dr. Mackey appointed effective April 5, 2022; Board size increased from 8 to 9.","Former SVP of Pfizer Worldwide R&D and Director of Pfizer La Jolla Laboratories; led development of Sutent, Xalkori, Ibrance.","Received option to purchase 22,000 shares at closing price on appointment date, vesting monthly over 36 months.","Current board seats include AVID Bioservices, Rady Children's Hospital; prior boards include Trillium, Poseida, GW Pharma.","CEO highlights her expertise for advancing synthetic lethality pipeline including IDE397 and darovasertib."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-005384","json":"https://secwatch.observer/filing/0000950170-22-005384.json","markdown":"https://secwatch.observer/filing/0000950170-22-005384.md","text":"https://secwatch.observer/filing/0000950170-22-005384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676725/000095017022005384/0000950170-22-005384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676725/000095017022005384/idya-20220405.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:08:10.286689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"68cbd4d1d1","claim":"Catherine J. Mackey was appointed as member of the Board of Directors at IDEAYA Biosciences, Inc..","evidence_excerpt":"On April 6, 2022, IDEAYA Biosciences, Inc. (the “Company”) announced the appointment of Catherine J. Mackey, Ph.D. as a member of its Board of Directors (the “Board”), effective April 5, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676725/000095017022005384/0000950170-22-005384-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}